Felicia Lospaluto
Adult Health · Greendale, WINPI 1780011908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 49.7% of the total. Reporting peaked in 2022 at $900 and has fallen 90.6% since, to $85 in 2024.
Across 109 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sunovion Pharmaceuticals Inc.$222
- Lundbeck LLC$163
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$163
- Neurocrine Biosciences, Inc.$124
- Jazz Pharmaceuticals Inc.$96
- plus $392 from 11 others
What the payments were for
- Food & beverage$2,309100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,309 in reported general payments places this provider in the 85th percentile of 170 adult health providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 15 | $21,146 |
| Aripiprazole | 19 | $8,486 |
| Lurasidone Hcl | 20 | $8,369 |
| Lamotrigine | 88 | $1,541 |
| Fluoxetine Hcl | 49 | $1,409 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $1,016 |
| Buspirone Hcl | 40 | $856 |
| Duloxetine Hcl | 46 | $771 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 39 | $731 |
| Imipramine Hcl | 14 | $586 |
| Risperidone | 43 | $479 |
| Quetiapine Fumarate | 30 | $478 |
| Clonazepam | 62 | $453 |
| Eszopiclone | 12 | $413 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,148 | $21,14615 claims |
| Almatica Pharma LLCSertraline Hcl | $20 | $28233 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 170 adult health providers in Wisconsin.
Other adult health in Greendale
- Dawn SagrilloWhitefish Bay$247K
- Lindsey SimpsonMuskego$67K
- Winsome PantonMilwaukee$46K
- Anatoliy VelikodanovMilwaukee$10K
- Tatjana StevanovicWest Allis$10K
- Annike CollinsMilwaukee$9K
- Kristine TwomeyNeenah$5K
- Kay ConradtAppleton$4K
- Nicole RosinMilwaukee$4K
- Robert FrankBrandon$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.